psychoanalysis,

As an introduction to the panel on "Aging, Dying, and the Analytic Process," and to the Focus of this issue of The Psychoanalytic Review , this article offers personal comments linked to affective neuropsychoanalytic theory, and advocates an ability to think about illness and death as an integral part of lived experience.

By revisiting the last years of a long psychoanalytic treatment of a female patient, a psychoanalyst reflects on her own development as a clinician and on the changes in her experience of psychoanalytic generativity. An increasing ability to understand patient's shifts between creativity and destructiveness brings about a different understanding of the process of mourning, while the shared aging of the analytic dyad highlights the difficulty of ending an analysis that has become a way of life.

No abstract text is available yet for this article.

Attention to the manifestations of death anxiety in the clinical context is often absent in the discourse of psychoanalytic training. This exchange addresses some of the causes of such an absence: a fraught relation between privacy and secrecy, primacy of psychic reality and interpretation, and cultural underpinnings of sanitization of death.

No abstract text is available yet for this article.

Offering a personal example, the author argues for the protocols of respectful, confidential, and responsible institutional support as a corrective to an individual clinician's lack of optimal judgment when facing difficult clinical challenges or personal crises.

This reflection on the initial stages of treatment of a latency girl whose previous analyst died offers some insights into inner workings of mourning in children. The mourning process intersects in complex ways with a developmental stage, object constancy, unconscious phantasies, and conscious ideas about life and death. Clinical material illustrates some challenges that emerge in the transference-countertransference matrix when working with a child who lost both her primary object (the mother) and her transference object (the analyst)...

The panel discussion presented at the New York Psychoanalytic Society and Institute's 1066th Scientific Meeting held on June 8, 2023, takes up aging and dying of an analyst and their impact on patients and on the nature of analytic process. Participants reflect on conflicts and challenges arising with more analysts and patients living to an advanced age, on the unregulated nature of analysts' retirement, and on multilayered meanings of analysts' ethical commitment to their work.

No abstract text is available yet for this article.

This appreciation of the work of Alan Roland reviews his pioneering contributions to the field of cross-cultural psychoanalysis based on the clinical experience with patients from non-Western cultures, most notably India and Japan.

No abstract text is available yet for this article.

The death of an analyst does not imply a socially sanctioned role for their analysand as a mourner. Through an account of experiences following her first analyst's death, the author reflects on the role of writing as a mode of grieving, on the impact of her subsequent analysis, and on the holding function of analytic community.

No abstract text is available yet for this article.

No abstract text is available yet for this article.

Addiction is a dynamic field. Its ongoing changes reflect a persistent but evolving public health problem. Its evolution is reflected in subsequent classifications of mental illness. Numerous theories, inspired by psychoanalysis and neurobiology, address the development of the addictive process an many factors explain differences in susceptibility between individuals. In the last decade, behavioural addictions have been the subject of intense debate, leading to the inclusion of gambling disorder in the latest classification...

BACKGROUND: Lysergic acid diethylamide (LSD) is a hallucinogenic agent. In the mid-20th century, it was used to augment psychoanalysis and to treat alcohol use disorder. However, LSD was banned in 1970 in part because of concerns that it could bring about or exacerbate mental illness. Its therapeutic potential remains incompletely understood. AREAS OF UNCERTAINTY: While uncontrolled recreational use of LSD can, in rare instances, lead to long-term psychosis, adverse events in clinical trials of LSD, such as anxiety, headache, and nausea, have almost always been mild and transient...

Whether the Swiss psychiatrist Carl Jung (1875-1961) became psychotic after his mid-thirties is much debated. His recently published Black Books, a seven-volume journal, reveal new insights into this debate. Based on a phenomenological analysis of his self-reports in these books and in other writings, we here identify several types of anomalous perceptual experiences: hypnagogic-hypnopompic experiences, hyperphantasia, hallucinations, personifications, and sensed presence. We argue that these experiences were not indicative of a psychotic disorder, but rather stemmed from extremely vivid mental imagery, or hyperphantasia, a condition Jung's contemporaries and later biographers were unable to take into account because it had not yet been conceptualised...

No abstract text is available yet for this article.

No abstract text is available yet for this article.

No abstract text is available yet for this article.